Janumet® Pancreatitis Lawsuit

PLEASE NOTE: Schmidt & Clark, LLP is no-longer accepting potential Janumet claims. If you feel that you have a case, we suggest that you locate another law firm experienced in mass tort litigation.

Janumet (sitagliptin/metformin) has recently been linked to an increased risk of serious life-threatening cases of pancreatitis, including acute, hemorrhagic and necrotizing pancreatitis.

Why You Should Choose Schmidt & Clark, LLP: Our law firm is one of the most active firms in the country regarding the ongoing Byetta pancreatitis litigation and was the first to file in the United States. We are currently accepting new Janumet pancreatitis and sitagliptin/metformin pancreatitis cases in all 50 states.

If you or a loved one have developed pancreatitis while taking Janumet or sitagliptin/metformin, you should contact us immediately. You may be entitled to compensation for your injuries and we can help.

What’s the problem?

On September 25, 2009 the U.S. Food & Drug Administration (FDA) notified healthcare professionals and patients of revisions to the prescribing information for Janumet (sitagliptin/metformin) and Januvia (sitagliptin) to include information on reported cases of acute pancreatitis in patients using these products. Eighty-eight post-marketing cases of acute pancreatitis, including two cases of hemorrhagic or necrotizing pancreatitis in patients using sitagliptin/metformin, were reported to the Agency between October 2006 and February 2009.

Side Effects of Janumet (sitagliptin/metformin)

Below is a list of the most serious side effects associated with Janumet and sitagliptin/metformin.

• Pancreatitis
• Acute Pancreatitis
• Hemorrhagic Pancreatitis
• Necrotizing Pancreatitis
• Death

Again, Schmidt & Clark, LLP is no-longer accepting potential Janumet claims. If you feel that you have a case, we suggest that you locate another law firm experienced in mass tort litigation.